Skip to content

Clinical trials

Enrolling by invitation trials in China with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Not applicable Status: Enrolling by invitation Country / region: China Clear all

240 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20171
20181
20192
20201
20215
20227
202314
202479
202587
202642

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Enrolling by invitation240

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ruijin Hospital6
Second Affiliated Hospital, Zhejiang University, School of Medicine6
Beijing Chao Yang Hospital5
Nanjing Medical University5
Peking University Third Hospital4
Shanghai Eye Disease Prevention and Treatment Center4
Xijing Hospital4
Affiliated Hospital of Jiaxing University3
First Affiliated Hospital of Ningbo University3
Fujian Medical University3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parkinson Disease5
Stroke5
Aortic Valve Stenosis4
Breast Neoplasms4
Cardiovascular Diseases4
Anxiety Disorders3
Atrial Fibrillation3
Cognitive Dysfunction3
Colorectal Neoplasms3
Coronary Artery Disease3

Trials

Showing 1 to 25 of 240. Each trial links to its page on Pharma Observatory.

140 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.